Literature DB >> 786881

Partial purification and characterization of a heat-labile enterotoxin of Escherichia coli.

I Schenkein, R F Green, D S Santos, W K Maas.   

Abstract

A partially purified enterotoxin was obtained from the growth medium of Escherichia coli strain 711 (P307), a derivative of E. coli K-12, by ultrafiltration, precipitation with ammonium sulfate, molecular sieving, and anion exchange column chromatography. The active moiety, which is heat-labile, behaved like a protein particle of 180,000 to 200,000 daltons during molecular sieving and ultracentrifugation. During polyacrylamide gel electrophoresis in sodium dodecyl sulfate (SDS-PAGE), it dissociated into two subunits with apparent molecular weights of 68,000 to 70,000 and 14,000 to 15,000. SDS-PAGE after heating in SDS changed the larger subunit to an apparent molecular weight of about 40,000; the smaller subunit did not change. The intact particle induced rounding of the cells in Y-1 mouse adrenal tumor cells used for assay. The detergent-dissociated molecules were not active. Proteolysis of the purified toxin by tolylsulfonyl phenylalanyl chloromethyl ketone-trypsin appeared to enhance its activity. The addition of serum to the assay medium resulted in partial depression of the activity. Activity was also abolished by preincubation of the toxin with either a rabbit antiserum to it or solutions containing GM1 ganglioside. The length of time needed to evoke a response in the assay system by fractions from different stages in the purification of the enterotoxin was a useful parameter in the evaluation of specific activity.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 786881      PMCID: PMC420823          DOI: 10.1128/iai.13.6.1710-1720.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Reduction of gamma-globulins.

Authors:  J B FLEISCHMAN; R H PAIN; R R PORTER
Journal:  Arch Biochem Biophys       Date:  1962-09       Impact factor: 4.013

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Escherichia coli enterotoxin. Purification and partial characterization.

Authors:  F Dorner
Journal:  J Biol Chem       Date:  1975-11-25       Impact factor: 5.157

4.  Fixation and inactivation of cholera toxin by GM1 ganglioside.

Authors:  J Holmgren; I Lönnroth; L Svennerholm
Journal:  Scand J Infect Dis       Date:  1973

5.  Preliminary characterization of the heat-labile enterotoxin of Escherichia coli F11(P155).

Authors:  S Lariviére; C L Gyles; D A Barnum
Journal:  J Infect Dis       Date:  1973-09       Impact factor: 5.226

6.  Properties of the enterotoxic component in Escherichia coli enteropathogenic for swine.

Authors:  T M Jacks; B J Wu; A C Braemer; D E Bidlack
Journal:  Infect Immun       Date:  1973-02       Impact factor: 3.441

7.  Deactivation of cholera toxin by ganglioside.

Authors:  W E Van Heyningen; C C Carpenter; N F Pierce; W B Greenough
Journal:  J Infect Dis       Date:  1971-10       Impact factor: 5.226

8.  Purification and some properties of a heat-labile enterotoxin from escherichia coli.

Authors:  O Söderlind; R Möllby; T Wadström
Journal:  Zentralbl Bakteriol Orig A       Date:  1974

9.  Comparison of the tissue receptors for Vibrio cholerae and Escherichia coli enterotoxins by means of gangliosides and natural cholera toxoid.

Authors:  J Holmgren
Journal:  Infect Immun       Date:  1973-12       Impact factor: 3.441

10.  Escherichia coli enterotoxin-induced steroidogenesis in cultured adrenal tumor cells.

Authors:  C N Kwan; R M Wishnow
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

View more
  17 in total

1.  Comparative studies of five heat-labile toxic products of Escherichia coli.

Authors:  J Konowalchuk; N Dickie; S Stavric; J I Speirs
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

2.  Purification and chemical characterization of the heat-labile enterotoxin produced by enterotoxigenic Escherichia coli.

Authors:  S L Kunkel; D C Robertson
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

3.  Purification and partial characterization of heat-stable enterotoxin of enterotoxigenic Escherichia coli.

Authors:  Y Takeda; T Takeda; T Yano; K Yamamoto; T Miwatani
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

4.  Immunological cross-reactivity between a heat-labile enterotoxin(s) of Escherichia coli and subunits of Vibrio cholerae enterotoxin.

Authors:  J D Clements; R A Finkelstein
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

5.  Purification and chemical characterization of the heat-stable enterotoxin produced by porcine strains of enterotoxigenic Escherichia coli.

Authors:  J F Alderete; D C Robertson
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

Review 6.  Pathophysiological effects of Vibrio cholerae and enterotoxigenic Escherichia coli and their exotoxins on eucaryotic cells.

Authors:  K L Richards; S D Douglas
Journal:  Microbiol Rev       Date:  1978-09

7.  Assay of Escherichia coli heat-labile enterotoxin with vero cells.

Authors:  J I Speirs; S Stavric; J Konowalchuk
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

8.  Escherichia coli heat-stable enterotoxin: rapid method of purification and some characteristics of the toxin.

Authors:  R Lallier; S Lariviere; S St-Pierre
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

9.  Nutritional requirements for synthesis of heat-labile enterotoxin by enterotoxigenic strains of Escherichia coli.

Authors:  P H Gilligan; D C Robertson
Journal:  Infect Immun       Date:  1979-01       Impact factor: 3.441

10.  Purification and characterization of salmolysin, an extracellular hemolytic toxin from Aeromonas salmonicida.

Authors:  S Nomura; M Fujino; M Yamakawa; E Kawahara
Journal:  J Bacteriol       Date:  1988-08       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.